Thomas H. Haines and Norbert A. Dencher (2002). "Cardiolipin: a proton trap for oxidative phosphorylation". FEBS Lett.528 (1–3): 35–39. PMID12297275. doi:10.1016/S0014-5793(02)03292-1.
M Garciafernandez, D Ceccarelli, U Muscatello (2004). "Use of the fluorescent dye 10-N-nonyl acridine orange in quantitative and location assays of cardiolipin: a study on different experimental models". Analytical Biochemistry328 (2): 174–180. PMID15113694. doi:10.1016/j.ab.2004.01.020.
Jacobson J, Duchen MR, Heales SJ. (2002). "Intracellular distribution of the fluorescent dye nonyl acridine orange responds to the mitochondrial membrane potential: implications for assays of cardiolipin and mitochondrial". Mass. J Neurochem82 (2): 224–233. doi:10.1046/j.1471-4159.2002.00945.x.
Keij JF, Bell-Prince C, Steinkamp JA. (2000). "Staining of mitochondrial membranes with 10-nonyl acridine orange, MitoFluor Green, and Mito-Tracker Green is affected by mitochondrial membrane potential altering drugs". Cytometry39 (3): 203–210. PMID10685077. doi:10.1002/(SICI)1097-0320(20000301)39:3<203::AID-CYTO5>3.0.CO;2-Z.
Xu Y., Malhotra A., Ren M. and Schlame M. (2006). "The enzymatic function of tafazzin". J. Biol. Chem.281 (51): 39217–39224. PMID17082194. doi:10.1074/jbc.M606100200.
Jenner P. (1991). "Oxidative stress as a cause of Parkinson's disease". Acta Neurol Scand Suppl136: 6–15. PMID12666096. doi:10.1002/ana.10483.
Ruggiero FM, Cafagna F, Petruzzella V, Gadaleta MN, Quagliariello E. (1991). "Lipid composition in synaptic and nonsynaptic mitochondria from rat brains and effect of aging". J Neurochem59 (2): 487–491. PMID12666096. doi:10.1002/ana.10483.
Dawson TM, Dawson VL. (2003). "Molecular pathways of neurodegeneration in Parkinson's disease". Science302 (5646): 819–822. PMID14593166. doi:10.1126/science.1087753.
Petrosillo G., Portincasa P., Grattagliano I., Casanova G., Matera M., Ruggiero F. M., Ferri D. and Paradies G. (2007). "Mitochondrial dysfunction in rat with nonalcoholic fatty liver: involvement of complex I, reactive oxygen species and cardiolipin". Biochim. Biophys. Acta.1767 (1): 1260–1267. PMID18973802. doi:10.1016/j.freeradbiomed.2008.09.031.
Fobker M., Voss R., Reinecke H., Crone C.,AssmannG. and Walter M. (2001). "Accumulation of cardiolipin and lysocardiolipin in fibroblasts from Tangier disease subjects". FEBS Lett.500 (3): 157–162. PMID11445077. doi:10.1016/S0014-5793(01)02578-9.
Gary J. Nabel (2005). "Immunology: Close to the Edge: Neutralizing the HIV-1 Envelope". Science308 (5730): 1878–1879. PMID15976295. doi:10.1126/science.1114854.
Erbrich U, Naujok A, Petschel K, Zimmermann HW (1982). "The fluorescent staining of mitochondria in living HeLa- and LM-cells with new acridine dyes". Histochemistry74 (1): 1–7. PMID7085344.
Thomas H. Haines and Norbert A. Dencher (2002). "Cardiolipin: a proton trap for oxidative phosphorylation". FEBS Lett.528 (1–3): 35–39. PMID12297275. doi:10.1016/S0014-5793(02)03292-1.
M Garciafernandez, D Ceccarelli, U Muscatello (2004). "Use of the fluorescent dye 10-N-nonyl acridine orange in quantitative and location assays of cardiolipin: a study on different experimental models". Analytical Biochemistry328 (2): 174–180. PMID15113694. doi:10.1016/j.ab.2004.01.020.
Keij JF, Bell-Prince C, Steinkamp JA. (2000). "Staining of mitochondrial membranes with 10-nonyl acridine orange, MitoFluor Green, and Mito-Tracker Green is affected by mitochondrial membrane potential altering drugs". Cytometry39 (3): 203–210. PMID10685077. doi:10.1002/(SICI)1097-0320(20000301)39:3<203::AID-CYTO5>3.0.CO;2-Z.
Baltazar Gomez Jr. and Neal C. Robinson (1999). "Phospholipase Digestion of Bound Cardiolipin Reversibly Inactivates Bovine Cytochrome bc1". Biochemistry38 (28): 9031–9038. PMID10413476. doi:10.1021/bi990603r.
Eble K.S.,ColemanW.B.,Hantgan R. R. and CunninghamC. (1990). "Tightly associated cardiolipin in the bovine heart mitochondrial ATP synthase as analyzed by 31P nuclear magnetic resonance spectroscopy". J. Biol. Chem.265 (32): 19434–19440. PMID2147180.
Xu Y., Malhotra A., Ren M. and Schlame M. (2006). "The enzymatic function of tafazzin". J. Biol. Chem.281 (51): 39217–39224. PMID17082194. doi:10.1074/jbc.M606100200.
Jenner P. (1991). "Oxidative stress as a cause of Parkinson's disease". Acta Neurol Scand Suppl136: 6–15. PMID12666096. doi:10.1002/ana.10483.
Ruggiero FM, Cafagna F, Petruzzella V, Gadaleta MN, Quagliariello E. (1991). "Lipid composition in synaptic and nonsynaptic mitochondria from rat brains and effect of aging". J Neurochem59 (2): 487–491. PMID12666096. doi:10.1002/ana.10483.
Dawson TM, Dawson VL. (2003). "Molecular pathways of neurodegeneration in Parkinson's disease". Science302 (5646): 819–822. PMID14593166. doi:10.1126/science.1087753.
Petrosillo G., Portincasa P., Grattagliano I., Casanova G., Matera M., Ruggiero F. M., Ferri D. and Paradies G. (2007). "Mitochondrial dysfunction in rat with nonalcoholic fatty liver: involvement of complex I, reactive oxygen species and cardiolipin". Biochim. Biophys. Acta.1767 (1): 1260–1267. PMID18973802. doi:10.1016/j.freeradbiomed.2008.09.031.
Fobker M., Voss R., Reinecke H., Crone C.,AssmannG. and Walter M. (2001). "Accumulation of cardiolipin and lysocardiolipin in fibroblasts from Tangier disease subjects". FEBS Lett.500 (3): 157–162. PMID11445077. doi:10.1016/S0014-5793(01)02578-9.
Gary J. Nabel (2005). "Immunology: Close to the Edge: Neutralizing the HIV-1 Envelope". Science308 (5730): 1878–1879. PMID15976295. doi:10.1126/science.1114854.